193 related articles for article (PubMed ID: 37938781)
1. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.
Le Voyer T; Parent AV; Liu X; Cederholm A; Gervais A; Rosain J; Nguyen T; Perez Lorenzo M; Rackaityte E; Rinchai D; Zhang P; Bizien L; Hancioglu G; Ghillani-Dalbin P; Charuel JL; Philippot Q; Gueye MS; Maglorius Renkilaraj MRL; Ogishi M; Soudée C; Migaud M; Rozenberg F; Momenilandi M; Riller Q; Imberti L; Delmonte OM; Müller G; Keller B; Orrego J; Franco Gallego WA; Rubin T; Emiroglu M; Parvaneh N; Eriksson D; Aranda-Guillen M; Berrios DI; Vong L; Katelaris CH; Mustillo P; Raedler J; Bohlen J; Bengi Celik J; Astudillo C; Winter S; ; ; McLean C; Guffroy A; DeRisi JL; Yu D; Miller C; Feng Y; Guichard A; Béziat V; Bustamante J; Pan-Hammarström Q; Zhang Y; Rosen LB; Holland SM; Bosticardo M; Kenney H; Castagnoli R; Slade CA; Boztuğ K; Mahlaoui N; Latour S; Abraham RS; Lougaris V; Hauck F; Sediva A; Atschekzei F; Sogkas G; Poli MC; Slatter MA; Palterer B; Keller MD; Pinzon-Charry A; Sullivan A; Droney L; Suan D; Wong M; Kane A; Hu H; Ma C; Grombiříková H; Ciznar P; Dalal I; Aladjidi N; Hie M; Lazaro E; Franco J; Keles S; Malphettes M; Pasquet M; Maccari ME; Meinhardt A; Ikinciogullari A; Shahrooei M; Celmeli F; Frosk P; Goodnow CC; Gray PE; Belot A; Kuehn HS; Rosenzweig SD; Miyara M; Licciardi F; Servettaz A; Barlogis V; Le Guenno G; Herrmann VM; Kuijpers T; Ducoux G; Sarrot-Reynauld F; Schuetz C; Cunningham-Rundles C; Rieux-Laucat F; Tangye SG; Sobacchi C; Doffinger R; Warnatz K; Grimbacher B; Fieschi C; Berteloot L; Bryant VL; Trouillet Assant S; Su H; Neven B; Abel L; Zhang Q; Boisson B; Cobat A; Jouanguy E; Kampe O; Bastard P; Roifman CM; Landegren N; Notarangelo LD; Anderson MS; Casanova JL; Puel A
Nature; 2023 Nov; 623(7988):803-813. PubMed ID: 37938781
[TBL] [Abstract][Full Text] [Related]
2. Nfkb2 variants reveal a p100-degradation threshold that defines autoimmune susceptibility.
Wirasinha RC; Davies AR; Srivastava M; Sheridan JM; Sng XYX; Delmonte OM; Dobbs K; Loh KL; Miosge LA; Lee CE; Chand R; Chan A; Yap JY; Keller MD; Chen K; Rossjohn J; La Gruta NL; Vinuesa CG; Reid HH; Lionakis MS; Notarangelo LD; Gray DHD; Goodnow CC; Cook MC; Daley SR
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33107914
[TBL] [Abstract][Full Text] [Related]
3. CD40 regulates the processing of NF-kappaB2 p100 to p52.
Coope HJ; Atkinson PG; Huhse B; Belich M; Janzen J; Holman MJ; Klaus GG; Johnston LH; Ley SC
EMBO J; 2002 Oct; 21(20):5375-85. PubMed ID: 12374738
[TBL] [Abstract][Full Text] [Related]
4. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
Yang CH; Murti A; Pfeffer LM
J Biol Chem; 2005 Sep; 280(36):31530-6. PubMed ID: 16009713
[TBL] [Abstract][Full Text] [Related]
5. p100/IκBδ sequesters and inhibits NF-κB through kappaBsome formation.
Tao Z; Fusco A; Huang DB; Gupta K; Young Kim D; Ware CF; Van Duyne GD; Ghosh G
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):15946-51. PubMed ID: 25349408
[TBL] [Abstract][Full Text] [Related]
6. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.
Yilmaz ZB; Weih DS; Sivakumar V; Weih F
EMBO J; 2003 Jan; 22(1):121-30. PubMed ID: 12505990
[TBL] [Abstract][Full Text] [Related]
7. A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs.
Mukherjee T; Chatterjee B; Dhar A; Bais SS; Chawla M; Roy P; George A; Bal V; Rath S; Basak S
EMBO J; 2017 Dec; 36(23):3501-3516. PubMed ID: 29061763
[TBL] [Abstract][Full Text] [Related]
8. NF-κB2/p100 deficiency impairs immune responses to T-cell-independent type 2 antigens.
Krljanac B; Weih D; Jacobsen ID; Hu D; Koliesnik I; Reppe K; Witzenrath M; Weih F
Eur J Immunol; 2014 Mar; 44(3):662-72. PubMed ID: 24242887
[TBL] [Abstract][Full Text] [Related]
9. NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications.
Bodansky A; Vazquez SE; Chou J; Novak T; Al-Musa A; Young C; Newhams M; Kucukak S; Zambrano LD; Mitchell A; Wang CY; Moffitt K; Halasa NB; Loftis LL; Schwartz SP; Walker TC; Mack EH; Fitzgerald JC; Gertz SJ; Rowan CM; Irby K; Sanders RC; Kong M; Schuster JE; Staat MA; Zinter MS; Cvijanovich NZ; Tarquinio KM; Coates BM; Flori HR; Dahmer MK; Crandall H; Cullimore ML; Levy ER; Chatani B; Nofziger R; ; Geha RS; DeRisi J; Campbell AP; Anderson M; Randolph AG
J Allergy Clin Immunol; 2023 Apr; 151(4):926-930.e2. PubMed ID: 36509151
[TBL] [Abstract][Full Text] [Related]
10. The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis.
Novack DV; Yin L; Hagen-Stapleton A; Schreiber RD; Goeddel DV; Ross FP; Teitelbaum SL
J Exp Med; 2003 Sep; 198(5):771-81. PubMed ID: 12939342
[TBL] [Abstract][Full Text] [Related]
11. The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100.
Fusco AJ; Mazumder A; Wang VY; Tao Z; Ware C; Ghosh G
Sci Signal; 2016 Sep; 9(447):ra96. PubMed ID: 27678221
[TBL] [Abstract][Full Text] [Related]
12. p100 Deficiency is insufficient for full activation of the alternative NF-κB pathway: TNF cooperates with p52-RelB in target gene transcription.
Lovas A; Weidemann A; Albrecht D; Wiechert L; Weih D; Weih F
PLoS One; 2012; 7(8):e42741. PubMed ID: 22880094
[TBL] [Abstract][Full Text] [Related]
13. Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression.
Wang Z; Zhang B; Yang L; Ding J; Ding HF
J Biol Chem; 2008 Apr; 283(16):10698-706. PubMed ID: 18281283
[TBL] [Abstract][Full Text] [Related]
14. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.
Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K
J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765
[TBL] [Abstract][Full Text] [Related]
15. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
16. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
17. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.
Meisel C; Akbil B; Meyer T; Lankes E; Corman VM; Staudacher O; Unterwalder N; Kölsch U; Drosten C; Mall MA; Kallinich T; Schnabel D; Goffinet C; von Bernuth H
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061776
[TBL] [Abstract][Full Text] [Related]
18. Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
Yeo SK; French R; Spada F; Clarkson R
Breast Cancer Res Treat; 2017 Apr; 162(3):465-477. PubMed ID: 28190248
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.
Xiao G; Harhaj EW; Sun SC
Mol Cell; 2001 Feb; 7(2):401-9. PubMed ID: 11239468
[TBL] [Abstract][Full Text] [Related]
20. Processing of the NF-kappa B2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation.
Maruyama T; Fukushima H; Nakao K; Shin M; Yasuda H; Weih F; Doi T; Aoki K; Alles N; Ohya K; Hosokawa R; Jimi E
J Bone Miner Res; 2010 May; 25(5):1058-67. PubMed ID: 19874202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
